Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension
Angelo P. Tanna, Mark Johnson
Ophthalmology (2018) Vol. 125, Iss. 11, pp. 1741-1756
Open Access | Times Cited: 225

Showing 1-25 of 225 citing articles:

Rho GTPase signaling in cancer progression and dissemination
Eva Crosas‐Molist, Rémi Samain, Leonie Kohlhammer, et al.
Physiological Reviews (2021) Vol. 102, Iss. 1, pp. 455-510
Open Access | Times Cited: 164
Immune responses to injury and their links to eye disease
Mary Ann Stepp, A. Sue Menko
Translational research (2021) Vol. 236, pp. 52-71
Open Access | Times Cited: 131
Updates on the Diagnosis and Management of Glaucoma
Isabella V. Wagner, Michael W. Stewart, Syril Dorairaj
Mayo Clinic Proceedings Innovations Quality & Outcomes (2022) Vol. 6, Iss. 6, pp. 618-635
Open Access | Times Cited: 72
A multi-cohort genome-wide association study in African ancestry individuals reveals risk loci for primary open-angle glaucoma
Shefali S. Verma, Harini V. Gudiseva, Venkata Ramana Murthy Chavali, et al.
Cell (2024) Vol. 187, Iss. 2, pp. 464-480.e10
Open Access | Times Cited: 24
Acute lung injury: The therapeutic role of Rho kinase inhibitors
Farshad Abedi, A. Wallace Hayes, Rüssel J. Reiter, et al.
Pharmacological Research (2020) Vol. 155, pp. 104736-104736
Closed Access | Times Cited: 106
Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment
Barbara Cvenkel, Miriam Kolko
Journal of Ophthalmology (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 87
Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension
Makoto Aihara, Fenghe Lu, Hisashi Kawata, et al.
American Journal of Ophthalmology (2020) Vol. 220, pp. 53-63
Open Access | Times Cited: 84
New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost
Nikki A. Mehran, Sapna Sinha, Reza Razeghinejad
Eye (2019) Vol. 34, Iss. 1, pp. 72-88
Open Access | Times Cited: 77
Cellular crosstalk regulates the aqueous humor outflow pathway and provides new targets for glaucoma therapies
Benjamin R. Thomson, Pan Liu, Tuncer Onay, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 61
Newer advances in medical management of glaucoma
Neethu Mohan, Arup Chakrabarti, Nazneen Nazm, et al.
Indian Journal of Ophthalmology (2022) Vol. 70, Iss. 6, pp. 1920-1930
Open Access | Times Cited: 51
Medical therapy for glaucoma: A review
Robert J. Casson
Clinical and Experimental Ophthalmology (2022) Vol. 50, Iss. 2, pp. 198-212
Closed Access | Times Cited: 42
Endothelial cytoskeleton in mechanotransduction and vascular diseases
Linlu Jin, Yixue Qin, Yili Zhao, et al.
Journal of Biomechanics (2025) Vol. 182, pp. 112579-112579
Closed Access | Times Cited: 1
Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye
Kuei‐Ju Cheng, Chien‐Ming Hsieh, Kunal Nepali, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 19, pp. 10533-10593
Closed Access | Times Cited: 53
A tissue-engineered human trabecular meshwork hydrogel for advanced glaucoma disease modeling
Haiyan Li, Tyler Bagué, Alexander Kirschner, et al.
Experimental Eye Research (2021) Vol. 205, pp. 108472-108472
Open Access | Times Cited: 44
Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases
Bao‐Guo Xiao, Cun‐Gen Ma, Qing Wang, et al.
Neural Regeneration Research (2022) Vol. 17, Iss. 12, pp. 2623-2623
Open Access | Times Cited: 31
Neuroprotection in glaucoma
Srinivasan Kavitha, CR Vishwaraj, Rengaraj Venkatesh, et al.
Indian Journal of Ophthalmology (2022) Vol. 70, Iss. 2, pp. 380-385
Open Access | Times Cited: 29
Exploring a Novel Fasudil-Phospholipid Complex Formulated as Liposomal Thermosensitive in situ Gel for Glaucoma
Aya M Khallaf, Riham M. El‐Moslemany, Mahmoud F. Ahmed, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 163-181
Open Access | Times Cited: 28
Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future Perspectives
Yuting Xie, Yue Lin, Yao Shi, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4342-4360
Closed Access | Times Cited: 21
The concept of gene therapy for glaucoma
Robert Sulak, Xiaonan Liu, Adrian Smędowski
Neural Regeneration Research (2023) Vol. 19, Iss. 1, pp. 92-99
Open Access | Times Cited: 17
Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball
Rongyue Xue, Hao Wu, Siyu Li, et al.
Materials Today Bio (2024) Vol. 27, pp. 101126-101126
Open Access | Times Cited: 7
The Application of Rho Kinase Inhibitors in the Management of Glaucoma
L Liu, Yi‐Hao Chen, Da‐Wen Lu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5576-5576
Open Access | Times Cited: 6
Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date
Lily Dasso, Tala Al-Khaled, Sriram Sonty, et al.
Clinical ophthalmology (2018) Vol. Volume 12, pp. 1939-1944
Open Access | Times Cited: 48
Neuro-protection and neuro-regeneration of the optic nerve: recent advances and future directions
Kimberly K. Gokoffski, Micalla G. Peng, Basheer Alas, et al.
Current Opinion in Neurology (2019) Vol. 33, Iss. 1, pp. 93-105
Open Access | Times Cited: 47
Microinvasive glaucoma surgery: A review of 3476 eyes
Prem Nichani, Marko Popović, Matthew B. Schlenker, et al.
Survey of Ophthalmology (2020) Vol. 66, Iss. 5, pp. 714-742
Closed Access | Times Cited: 47
Rho-kinase inhibitors in the management of glaucoma
Emanuela Berrino, Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2019) Vol. 29, Iss. 10, pp. 817-827
Closed Access | Times Cited: 46
Page 1 - Next Page

Scroll to top